Absence of estrogen receptor-β expression in metastatic ovarian cancer

被引:151
作者
Rutherford, T
Brown, WD
Sapi, E
Aschkenazi, S
Muñoz, A
Mor, G
机构
[1] Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA
关键词
D O I
10.1016/S0029-7844(00)00917-0
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the expression of estrogen receptor (ER)alpha and ER beta mRNA and protein in normal ovarian tissue and primary and metastatic tumors. Methods: Estrogen receptor or and ER beta expression was studied in normal ovarian biopsies (n = 9) and primary (n = 8) and metastatic ovarian epithelial cancers (n = 8). Ovarian tissue was collected from surgical samples. Estrogen receptor cu and ER beta mRNA expression was compared by coamplification of the mRNA of the ERs. Expression was confirmed at the protein level by Western blot analysis using antibodies specific for each receptor. Results: Among eight primary ovarian cancer samples, three had only ER alpha, two had only ER beta, and three had both. All eight metastatic ovarian cancer tissues expressed only ER alpha mRNA and protein. Biopsies from normal ovaries had ER alpha and ER beta mRNA and protein. Two of the ovarian epithelial cancer samples were paired and showed the same results. Conclusion: We found varying amounts of ER alpha and ER beta in normal ovaries, lower levels of ER beta expression in ovarian epithelial cancer primary tumors, and only ER alpha in metastatic tumors. Our findings indicate that a fundamental difference might exist between primary and metastatic cells, which could be caused by intrinsic or extrinsic factors that regulate ER gene expression. (Obstet Gynecol 2000;96:417-21. (C) 2000 by The American College of Obstetricians and Gynecologists.).
引用
收藏
页码:417 / 421
页数:5
相关论文
共 26 条
[1]   ROLE OF THE 2 ACTIVATING DOMAINS OF THE ESTROGEN-RECEPTOR IN THE CELL-TYPE AND PROMOTER-CONTEXT DEPENDENT AGONISTIC ACTIVITY OF THE ANTIESTROGEN 4-HYDROXYTAMOXIFEN [J].
BERRY, M ;
METZGER, D ;
CHAMBON, P .
EMBO JOURNAL, 1990, 9 (09) :2811-2818
[2]   Estrogen receptor alpha (ER-α) and beta (ER-β) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines:: Down-regulation of ER-β in neoplastic tissues [J].
Brandenberger, AW ;
Tee, MK ;
Jaffe, RB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) :1025-1028
[3]   Estrogen receptor-beta mRNA expression in rat ovary: Down-regulation by gonadotropins [J].
Byers, M ;
Kuiper, GGJM ;
Gustafsson, JA ;
ParkSarge, OK .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (02) :172-182
[4]   Estrogen action in human ovarian cancer [J].
Clinton, GM ;
Hua, WH .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1997, 25 (01) :1-9
[5]   A comparison of transcriptional activation by ERα and ERβ [J].
Cowley, SM ;
Parker, MG .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1999, 69 (1-6) :165-175
[6]   THE STEROID AND THYROID-HORMONE RECEPTOR SUPERFAMILY [J].
EVANS, RM .
SCIENCE, 1988, 240 (4854) :889-895
[7]   The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens [J].
Hall, JM ;
McDonnell, DP .
ENDOCRINOLOGY, 1999, 140 (12) :5566-5578
[8]   AN EPIDEMIOLOGIC-STUDY OF EPITHELIAL CARCINOMA OF THE OVARY [J].
HILDRETH, NG ;
KELSEY, JL ;
LIVOLSI, VA ;
FISCHER, DB ;
HOLFORD, TR ;
MOSTOW, ED ;
SCHWARTZ, PE ;
WHITE, C .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1981, 114 (03) :398-405
[9]   Expression of oestrogen receptor α and β in cultured human ovarian surface epithelial cells [J].
Hillier, SG ;
Anderson, RA ;
Williams, ARW ;
Tetsuka, M .
MOLECULAR HUMAN REPRODUCTION, 1998, 4 (08) :811-815
[10]   The novel estrogen receptor-beta subtype: Potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens [J].
Kuiper, GGJM ;
Gustafsson, JA .
FEBS LETTERS, 1997, 410 (01) :87-90